- Home
- IPDN vs ADTX Comparison
IPDN vs ADTX Comparison
Compare IPDN & ADTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPDN
- ADTX
- Stock Information
- Founded
- IPDN 2003
- ADTX 2017
- Country
- IPDN United States
- ADTX United States
- Employees
- IPDN N/A
- ADTX N/A
- Industry
- IPDN EDP Services
- ADTX Biotechnology: Pharmaceutical Preparations
- Sector
- IPDN Technology
- ADTX Health Care
- Exchange
- IPDN Nasdaq
- ADTX Nasdaq
- Market Cap
- IPDN 5.2M
- ADTX 4.9M
- IPO Year
- IPDN 2013
- ADTX 2020
- Fundamental
- Price
- IPDN $3.38
- ADTX $0.30
- Analyst Decision
- IPDN
- ADTX
- Analyst Count
- IPDN 0
- ADTX 0
- Target Price
- IPDN N/A
- ADTX N/A
- AVG Volume (30 Days)
- IPDN 234.3K
- ADTX 2.6M
- Earning Date
- IPDN 11-13-2025
- ADTX 11-17-2025
- Dividend Yield
- IPDN N/A
- ADTX N/A
- EPS Growth
- IPDN N/A
- ADTX N/A
- EPS
- IPDN N/A
- ADTX N/A
- Revenue
- IPDN $6,459,379.00
- ADTX $12,051.00
- Revenue This Year
- IPDN N/A
- ADTX $15,768.94
- Revenue Next Year
- IPDN N/A
- ADTX N/A
- P/E Ratio
- IPDN N/A
- ADTX N/A
- Revenue Growth
- IPDN N/A
- ADTX N/A
- 52 Week Low
- IPDN $0.97
- ADTX $0.29
- 52 Week High
- IPDN $12.39
- ADTX $267.50
- Technical
- Relative Strength Index (RSI)
- IPDN 47.03
- ADTX 19.51
- Support Level
- IPDN $3.72
- ADTX $0.67
- Resistance Level
- IPDN $3.83
- ADTX $0.57
- Average True Range (ATR)
- IPDN 0.41
- ADTX 0.06
- MACD
- IPDN -0.02
- ADTX -0.03
- Stochastic Oscillator
- IPDN 32.17
- ADTX 1.40
About IPDN Professional Diversity Network Inc.
Professional Diversity Network Inc is engaged in providing access to networking, training, educational and employment services to its registered users. It has three operating segments: the TalentAlly Network segment, which maintains and operates job board software and hosts career fairs; the National Association of Professional Women (NAPW) segment, which is a women-only professional networking organization; the RemoteMore segment; and Corporate Overhead. The company generates majority of its revenue from TalentAlly Network Segment.
About ADTX Aditxt Inc.
Aditxt Inc is a life sciences company that develops, builds, and grows innovations with a focus on monitoring and modulating the immune system. It develops products designed to induce tolerance to transplanted organs. Its portfolio consists of two programs Adimune and AditxtScore. It firm's immunosuppressive (anti-rejection) drugs have made possible life-saving organ transplantation procedures and blocking of unwanted immune responses in autoimmune diseases. It is also developing a technology called Apoptotic DNA Immunotherapy (ADi) ADI-100, which utilizes a novel approach that mimics, the way bodies naturally induce tolerance to tissues.